Muscle Ultrasound for Sarcopenia Leading to Early Detection
MUSCLED
Revisiting the Sarcopenia Diagnosis: New Approaches to Rapid Screening and Preventative Healthcare
2 other identifiers
observational
34
1 country
1
Brief Summary
Sarcopenia is an age-related loss of muscle mass that may affect over 25% of individuals over the age of 60 and results in a 3 to 4 times increased likelihood of developing a disability. Despite these observations, sarcopenia is rarely subject to a systematic screening process as a part of customary geriatric care. Furthermore, when lean body mass (LBM) is measured via dual energy X-ray absorptiometry (DXA) in older adults, it is typically within a reactive, hospital-based, model of healthcare where muscle wasting is only assessed after a loss of functional independence. The investigators propose an affordable, portable screening method with ultrasound imaging to be performed in primary care settings. The investigators long term goal is to identify individuals at risk, and intervene with treatments that may prevent the onset of debilitating loss of muscle function in the elderly.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
December 15, 2014
CompletedFirst Posted
Study publicly available on registry
December 18, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedMarch 1, 2018
February 1, 2018
1.8 years
December 15, 2014
February 28, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sonographic Lean Body Mass
US estimates of aggregate regional LBM (muscle thickness, cm), will be assessed using B-mode diagnostic US with a 13-6 megahertz linear array transducer for morphology measures at 5 axial and appendicular sites.
1 day
Secondary Outcomes (4)
DXA lean body mass
1 day
Grip strength
1 day
Lower extremity function
1 day
Physical activity questionnaire
1 day
Study Arms (2)
Reference Group
18 - 29 years of age; apparently healthy younger participants; 1:1 male and female recruitment ratio (Exposure include DXA scanning).
Comparison Group
55 - 75 years of age; apparently healthy older participants; 1:1 male and female recruitment ratio (Exposure include DXA scanning).
Interventions
Exposure: Participants will undergo DXA scanning in the supine position per manufacturer guidelines to estimate absolute and percentage of total lean body mass (LBM) and body fat (BF).
Eligibility Criteria
Enrolled subjects in this pilot study will include a healthy young reference group (18 - 29 years of age) and an older comparison group (55 - 75 years of age; n = 15 per group; approximately 50% female), consecutively recruited from George Washington University and the surrounding community.
You may qualify if:
- You are between the ages of 18 - 29 years, or 55 - 75 years.
- You must be able to stand comfortably for 10 minutes and walk a short distance (use of assistive devices are acceptable).
You may not qualify if:
- You have a medical condition that results in edema.
- You have had an upper or a lower extremity amputation.
- You are, or may be, pregnant.
- You have a body mass index (BMI) \> 30.0.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- George Washington Universitylead
- National Institutes of Health (NIH)collaborator
- Children's National Research Institutecollaborator
Study Sites (1)
George Washington University
Washington D.C., District of Columbia, 20052, United States
Related Publications (1)
Harris-Love MO, Monfaredi R, Ismail C, Blackman MR, Cleary K. Quantitative ultrasound: measurement considerations for the assessment of muscular dystrophy and sarcopenia. Front Aging Neurosci. 2014 Jul 14;6:172. doi: 10.3389/fnagi.2014.00172. eCollection 2014. No abstract available.
PMID: 25071570BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Loretta DiPietro, PhD, MPH
George Washington University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2014
First Posted
December 18, 2014
Study Start
February 1, 2014
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
March 1, 2018
Record last verified: 2018-02